Cleared Traditional

K911771 - ARD(TM) ANTIMICROBIAL REMOVAL DEVICE

K911771 is an FDA 510(k) clearance for ARD(TM) ANTIMICROBIAL REMOVAL DEVICE, manufactured by Bd Becton Dickinson Vacutainer Systems Preanalytic. The device is a Class 2 Microbiology device with product code LJK cleared through the Traditional 510(k) pathway after a 73-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 1991
Decision
73d
Days
Class 2
Risk

K911771 is an FDA 510(k) clearance for the ARD(TM) ANTIMICROBIAL REMOVAL DEVICE. Classified as Antisera, If, Toxoplasma Gondii (product code LJK), Class II - Special Controls.

Submitted by Bd Becton Dickinson Vacutainer Systems Preanalytic (Franklin Lakes, US). The FDA issued a Cleared decision on July 1, 1991 after a review of 73 days - a notably fast clearance cycle.

This device falls under the Microbiology FDA review panel, regulated under 21 CFR 866.3780 - the FDA microbiology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

FDA 510(k) Submission Details - K911771

510(k) Number K911771 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 19, 1991
Decision Date July 01, 1991
Days to Decision 73 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
29d faster than avg
Panel avg: 102d · This submission: 73d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LJK Device Classification - Class 2, Special Controls

Product Code LJK Antisera, If, Toxoplasma Gondii
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.3780
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Microbiology devices follow this clearance model.

Regulatory Peers - LJK Antisera, If, Toxoplasma Gondii

Devices cleared under the same product code (LJK) and FDA review panel - the closest regulatory comparables to K911771.
ACCURUN 135 TOXOPLASMA IGG POSITIVE CONTROL
K974261 · Boston Biomedica, Inc. · Dec 1997
THE GOLDEN QUAD TEST (TOXO)
K861122 · Microbiological Research Corp. · Feb 1987
SOLID STATE CONTINUOUS FLOW CONTROL MODEL W/K101
K861460 · Widran Urological Group, Ltd. · May 1986
TOXO IPA KIT IAN INDIRECT FLUORESCENT
K832069 · Bionetic Laboratory Products · Sep 1983
TOXOPLASMA GONDII ANTIBODY IGG
K822605 · Immulok, Inc. · Oct 1982